Chemed Co. (NYSE:CHE) Shares Sold by Envestnet Portfolio Solutions Inc.

Envestnet Portfolio Solutions Inc. trimmed its holdings in shares of Chemed Co. (NYSE:CHE) by 2.5% in the fourth quarter, Holdings Channel reports. The firm owned 1,268 shares of the company’s stock after selling 33 shares during the period. Envestnet Portfolio Solutions Inc.’s holdings in Chemed were worth $672,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. State Street Corp increased its position in shares of Chemed by 0.8% during the third quarter. State Street Corp now owns 464,354 shares of the company’s stock valued at $279,063,000 after acquiring an additional 3,564 shares during the last quarter. Geode Capital Management LLC increased its holdings in Chemed by 4.9% in the 3rd quarter. Geode Capital Management LLC now owns 335,443 shares of the company’s stock valued at $201,820,000 after purchasing an additional 15,791 shares during the last quarter. Boston Trust Walden Corp raised its position in Chemed by 10.0% in the fourth quarter. Boston Trust Walden Corp now owns 242,172 shares of the company’s stock valued at $128,303,000 after purchasing an additional 22,105 shares during the period. FMR LLC lifted its stake in Chemed by 23.8% during the third quarter. FMR LLC now owns 238,616 shares of the company’s stock worth $143,401,000 after purchasing an additional 45,917 shares in the last quarter. Finally, Copeland Capital Management LLC boosted its position in shares of Chemed by 16.8% during the fourth quarter. Copeland Capital Management LLC now owns 151,623 shares of the company’s stock worth $80,330,000 after buying an additional 21,834 shares during the period. 95.85% of the stock is currently owned by hedge funds and other institutional investors.

Chemed Stock Up 2.2 %

NYSE:CHE opened at $606.93 on Tuesday. The company has a market cap of $8.88 billion, a price-to-earnings ratio of 30.67, a price-to-earnings-growth ratio of 2.15 and a beta of 0.43. Chemed Co. has a 52 week low of $512.12 and a 52 week high of $648.29. The company has a fifty day simple moving average of $569.25 and a two-hundred day simple moving average of $565.58.

Chemed Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, March 14th. Shareholders of record on Monday, February 24th were issued a dividend of $0.50 per share. The ex-dividend date of this dividend was Monday, February 24th. This represents a $2.00 annualized dividend and a yield of 0.33%. Chemed’s dividend payout ratio (DPR) is 10.05%.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on the company. StockNews.com raised Chemed from a “hold” rating to a “buy” rating in a research note on Friday, March 7th. Royal Bank of Canada increased their price target on shares of Chemed from $633.00 to $667.00 and gave the stock an “outperform” rating in a research report on Friday, March 14th.

Insider Buying and Selling at Chemed

In other Chemed news, VP Brian C. Judkins purchased 145 shares of the business’s stock in a transaction on Monday, December 30th. The shares were bought at an average cost of $519.50 per share, for a total transaction of $75,327.50. Following the completion of the purchase, the vice president now directly owns 1,678 shares in the company, valued at approximately $871,721. This represents a 9.46 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the company’s stock in a transaction dated Thursday, March 6th. The stock was sold at an average price of $593.67, for a total value of $1,187,340.00. Following the transaction, the chief executive officer now directly owns 102,679 shares of the company’s stock, valued at approximately $60,957,441.93. This represents a 1.91 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 3.32% of the stock is owned by corporate insiders.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.